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Abstract
Mindfulness-based group therapy is a rapidly growing psychological approach that can potentially help people adjust to chronic
illness and manage unpleasant symptoms. Emerging evidence suggests that mindfulness-based interventions may benefit people
with Parkinson’s. The objective of the paper is to examine the appropriateness, feasibility, and potential cost-effectiveness of an
online mindfulness intervention, designed to reduce anxiety and depression for people with Parkinson’s. We conducted a fea-
sibility randomized control trial and qualitative interviews. Anxiety, depression, pain, insomnia, fatigue, impact on daily activities
and health-related quality of life were measured at baseline, 4, 8, and 20 weeks. Semi-structured interviews were conducted at the
end of the intervention. Participants were randomized to the Skype delivered mindfulness group (n ¼ 30) or wait-list (n ¼ 30).
Participants in the mindfulness group were also given a mindfulness manual and a CD with mindfulness meditations. The inter-
vention did not show any significant effects in the primary or secondary outcome measures. However, there was a significant
increase in the quality of life measure. The incremental cost-effectiveness ratio was estimated to be £27,107 per Quality-Adjusted
Life Year gained. Also, the qualitative study showed that mindfulness is a suitable and acceptable intervention. It appears feasible to
run a trial delivering mindfulness through Skype, and people with Parkinson’s found the sessions acceptable and helpful.
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Introduction
Anxiety and depression are prevalent in people with Parkin-
son’s (PwP). Depending on the criteria used, depression
affects up to 50% of PwP,1 and up to 31% report some level
of anxiety.2 Even when PwP do not experience significant
psychological disorders, they may still struggle to adjust to
the social, emotional and personal changes brought on by the
condition.
Recent reviews and meta-analyses have shown that cogni-
tive behavioural therapy (CBT) interventions are promising
treatment approaches when addressing psychological distress
in Parkinson’s.3-8 Due to mobility limitations, travel burden
and cost, psychological treatment can be inaccessible in Par-
kinson’s, and the conditions have definitely been intensified by
the implementation of lockdown during the COVID-19 pan-
demic.9 Therefore, there has been a recent shift toward deliver-
ing care remotely.10 Preliminary evidence shows that remotely
delivered CBT interventions can improve psychological well-
being for people affected by Parkinson’s.11-13
Further, mindfulness-based group therapy, typically an
8-week course of weekly meetings and daily mindfulness
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meditation practice, is a rapidly growing psychological
approach that can potentially help people adjust to chronic
illness and manage unpleasant symptoms.14 Mindfulness
focuses on finding a new way to relate to thoughts and experi-
ences and to accept them as passing events that do not neces-
sarily represent a state of reality.15 Mindfulness is based on the
philosophy that human suffering develops in part by efforts to
struggle with and avoid our own psychological and emotional
pain. Changing one’s relationship to thoughts appears to be the
most active component of mindfulness-based interventions
(MBIs).15
Emerging evidence suggests that MBIs may benefit the
PwP. Four recent small randomized control trials (n ¼ 29,
30, 14, and 36) of MBI showed significant decreases in motor
symptoms16-18 symptoms of depression,16,19,20 and symptoms
of anxiety16 for PwP and showed an increase in gray matter
density in the hippocampus and amygdala.17 Importantly, a
qualitative study evaluating the acceptability and feasibility
of this approach in a group of PwP has found that this form
of intervention is well accepted and described as both challen-
ging and life-enhancing.21 In addition, MBI have frequently
been found to provide good value for money, being cost-saving
treatments while improving health-related quality of life
(HRQoL) for distressed patients.14,22
We delivered a MBI via Skype, an online application that
enables video conferences with 2 or more people. There is
evidence that distant delivered MBIs can be effective in people
with chronic medical conditions.10,14,23-25 The overall objec-
tive of this study was to assess the potential feasibility and
acceptability of an MBI for PwP delivered via Skype.
The specific aims of this trial were to:
1. Examine recruitment, retention, and attendance to the
mindfulness sessions to establish the feasibility of the
current protocol for future larger-scale efficacy trials.
2. Evaluate the potential efficacy of the MBI regarding
improvements in anxiety, depression, pain, insomnia,
fatigue, and daily activities.
3. Evaluate the potential effectiveness of the distant deliv-
ered MBI regarding improvements in HRQoL measures
and provide a rough estimate of the cost-effectiveness
of the intervention.
4. Assess participants’ experiences of the MBI to contrib-
ute toward further protocol refinements.
Methods
Participants
We employed a parallel-group, randomized control trial
design. A trial of at least 30 participants is adequate for an
efficacy trial.26 Enrolment of 60 participants was planned,
anticipating a 10% dropout rate by 3 months. Participants were
randomly assigned to either an 8-week MBI course (n ¼ 30) or
a wait-list control (n ¼ 30). The control group was offered the
opportunity to take part in the mindfulness courses at the end of
the 3-month follow-up. CONSORT flow chart of the study is
summarized in Figure 1.
Participants were recruited through adverts on the Parkin-
son’s UK and the Michael J. Fox Foundation websites and
emails sent to the Parkinson’s UK Research Network. Recruit-
ment took place between February and March 2016.
Participants included in this study: had a self-reported diag-
nosis of Parkinson’s by a neurologist or geriatrician, had a
computer and internet access at home, they were able to com-
municate in English fluently and were stabilized on Parkin-
son’s medication, antidepressants or anxiolytics (if taken),
indicated by a stable dose for a minimum of 1 month. Partici-
pants were excluded from the study if they self-reported a
severe cognitive impairment that would make participation in
the mindfulness sessions and home practice of mindful medita-
tion problematic or distressing. Cognitive impairment was
assessed using the Telephone Interview for Cognitive Status
Instrument modified version.27 People with a score of less than
20 were excluded. People were also excluded if they reported
any severe psychiatric conditions (e.g. psychosis, drug/alcohol
abuse) that could potentially risk failure in the intervention or
limit participation in the course; had severe hearing impair-
ment, were participating in other psychological therapies at the
time or had prior formal training in mindfulness methods or a
current meditation practice.
Standard Protocol Approvals, Registration, Funding and
Patient Consents
Ethical approval was obtained from the City, University of
London Psychology Ethics Committee (reference: PSYETH
(S/F) 15/16 112) and registered with ClinicalTrials.gov
(NCT02683330) in January 2016. Funding was obtained from
Parkinson’s UK. The funders had no contribution to design,
analysis or write-up of the study. More details on the protocol
of the study have previously been published.28 All participants
completed written informed consent.
Randomization
Randomization took place once a cohort of 10 people had
consented, were screened and had their baseline data collected.
The trial coordinator (DS) conducted the randomization using a
computer-generated randomly permuted blocks scheme.
The randomization scheme was generated using the randomi-
sation.com website. This randomization scheme allowed for
keeping the groups in similar sizes, ensuring that the number
of participants in each treatment group was roughly equal at
any time during the trial. On receiving the randomization out-
come from DS, the mindfulness facilitator (AB) notified parti-
cipants of their group allocation, offered them a date for their
first session and sent them web-cameras and headsets. Partici-
pants in the wait-list group were asked to refrain from any new
mindfulness related activities during the trial. No participants
of the control group reported mindfulness related activities
during the waiting period. We used dummy codes in the data
2 Journal of Geriatric Psychiatry and Neurology XX(X)
file, to ensure the researchers involved in data analysis were
blinded to treatment group allocation until they completed the
primary analyses. The nature of the intervention meant it was
not feasible to keep the patients or treatment providers blind to
treatment allocation.
Mindfulness-Based Intervention
The MBI was delivered in 8 sessions over 8 weeks. The ses-
sions lasted 1 hour and were held via videoconference through
Skype, in groups of 5 people. The videoconferences were ini-
tiated by AB and were arranged at a day and time that was most
suitable for all participants in the group. The facilitator of the
group and the trial coordinator were available to help partici-
pants with setting up their equipment, use of Skype or other
technical difficulties via telephone. Participants were given
CDs with guided mindfulness meditations to follow. These
guided meditations also addressed potential issues PwP may
come across during practices, like resting tremor, spasms, fati-
gue and mind wandering.
The sessions were carried out based on a written manual —
additional details on the content of the intervention can be
found in the published protocol.28 The facilitator introduced
the same topics at the same time-points to all groups. However,
flexibility was allowed to repeat topics or discuss future topics
earlier than expected, if needed. Participants were sent the
mindfulness manual and a CD with the mindfulness medita-
tions before their first session and were encouraged to read only
the chapter relevant to the session each week. The manual
contained 8 chapters. In each section, the homework for each
week was outlined followed by a brief description of the
week’s theme.
The intervention manual was based on the Mindfulness-
Based Cognitive Therapy (MBCT) programme for depression
developed by Segal, Williams and Teasdale.15 We tailored the
programme to the needs of PwP. One of the main changes
introduced was the reduction of time in mindfulness home
practice to 20 minutes instead of the traditional 45 minutes.
Recent evidence suggests that frequency and not the duration
of the meditation practice is associated with positive psycho-
logical well-being.29 Further, we reduced the weekly group
Assessed for eligibility (n= 91)
Excluded  (n=28)
Prior mindfulness experience (n=9)
TICS-M score <20 (n=2)
Did not return consent forms (n=17)
Analysed  (n= 30)
Lost to follow-up (n= 9)
Discontinued intervention (n=8)
Non-response to questionnaire (n=1)
Allocated to mindfulness intervention (n=30)
Lost to follow-up (n=1)
Non-response to questionnaire (n=1)
Allocated to wait-list (n=30)












Figure 1. CONSORT flow diagram.
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sessions from 2/2.5 hours to 1 hour. Each session contained all
the elements of the sessions of the original protocol, all similar
concepts were introduced, such as acceptance, relating to
thoughts and self-compassion. However, the timings were sig-
nificantly reduced. For example, all sessions started with a
meditation practice that lasted 10 minutes instead of 45 min-
utes, followed by a 10 minutes inquiry compared to 20 minutes
of inquiry in the original protocol. Then another short medita-
tion practice followed this discussion, and in the end, home-
work for the next week was set. In previous studies the
correlation between mean effect size and number of in-class
hours was non-significant for both clinical and nonclinical
samples, suggesting that adaptations which include less class
time may be worthwhile for populations for whom longer time
commitment may be a barrier to their ability to participate.30
Shortened class time has been used successfully, for example,
in people with multiple sclerosis,31 and Parkinson’s.16
The manual also included Parkinson’s-specific examples.
These changes made the intervention more accessible and rel-
evant for PwP.
AB delivered the 8-week course. AB is a health psychologist
who has completed teachers’ training to deliver mindfulness-
based courses and has experience delivering mindfulness
programs for people with neurological conditions via video-
conference. LM, a clinical psychologist with experience in
mindfulness programs for people with long-term conditions
provided supervision.
AB recorded attendance and made notes on participation.
In the case of non-attendance at sessions, AB contacted the
participant to ascertain the problem and discuss a suitable solu-
tion, addressing any concerns. Because of the group setting of
this intervention participants did not have the opportunity to
reschedule a missed session.
Wait-List/ Control
Participants allocated to the wait-list group (“WLC group,”
hereafter) received the treatment they would normally expect
within the NHS—typically a mix of clinical input and review
from both primary and secondary care providers, according to
individual health needs.
Measures
Participants were assessed at 4-time points, baseline (pre-inter-
vention), 4 weeks (mid-intervention), 8 weeks (post-interven-
tion) and 20 weeks (follow-up). Assessments were completed
online. The patient-reported outcome measures (PROMs) used
for the assessment are detailed in the next sections.
Primary PROM. Hospital Anxiety and Depression Scale
(HADS)32 was used to assess symptoms of depression (7 items)
and anxiety (7 items). This scale is effective in assessing the
severity of symptoms of anxiety and depression in both sec-
ondary and primary care patients,33 and the instrument has been
proved to be reliable, valid, and responsive for use in PwP.34
Each item was scored on a scale of 0-3, with 3 indicating higher
symptom frequencies. Scores for each subscale (anxiety and
depression) were then totalled and ranged from 0-21.
Secondary PROMs. Brief Pain Inventory (BPI)35 measured pain
severity/intensity, as well as pain interference with daily life
across 7 domains. This is a numerical rating scale (scaled from
0 “does not interfere” to 10 “completely interferes”). This pain
scale was used to assess the average pain associated with
Parkinson’s.
Fatigue Severity Scale (FFS)36 has 9 items and was used to
assess the impact of fatigue on the daily living of patients. It is
comprised of 3 items related to physical impact, 3 items related
to the psychological environment and 3 more generic items.
Each item was rated on a 7-point Likert scale (1 ¼ completely
disagree—7 ¼ completely agree). Mean scores of 4 or more
defined significant fatigue.
Insomnia Severity Index (ISI)37 consists of 7 items that
assess the nature, severity, and impact of insomnia in the last
2 weeks. Each item was rated on a 5-point Likert scale (0¼ not
at all—4 ¼ extremely) with total scores ranging from 0 to 28,
whereby higher scores indicated greater insomnia severity.
Parkinson’s Disease Activities of Daily Living Scale
(PADLS)38 assessed difficulties in daily activities due to Par-
kinson’s. This 5-item scale was used to provide a single global
rating of how patients perceive their illness, with higher mean
scores indicating greater difficulty in activities of daily living.
We used this measure as a proxy for disease severity.
HRQoL measures. Quality-Adjusted Life Years (QALYs) is the
primary health outcome of interest in the cost-effectiveness
analysis. One QALY is the equivalent to 1 year of life in full
health. QALYs are therefore defined by weighting the life
years by the HRQoL they will be lived in. HRQoL in this
analysis is measured by the instrument EQ-5D-3 L.39
The instrument describes the quality of a health state by means
of 5 dimensions (mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression). Each health profile described
by means of the EQ-5D-3 L is mapped to a score (usually called
“social tariff” or “utility index,” since the index is based on
societal preferences over health states) that usually ranges from
0 to 1, with 0 indicating dead, and 1 representing full health.
QALYs is a globally accepted measure of HRQoL in economic
evaluations; in particular, the National Institute of Health and
Care Excellence (NICE) in England evaluates the cost-
effectiveness of health programs in terms of cost(£)-
per-QALY, with an explicit threshold specified in the NICE
assessment guidelines: an intervention that requires an invest-
ment in the range of £20,000 to £30,000 per QALY gained (or
below) is likely to be funded by the NHS.40
Feedback Interview Procedure
At the end of the 8-week intervention period participants in the
mindfulness, group were also interviewed by an MSc health
psychology student, who had no involvement in other aspects
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of the trial. Participants were asked to give open and honest
accounts of their experiences and opinions of the intervention
(see topic guide Table 1). All participants were asked the same
questions using the same prompts. Questions addressed expec-
tations regarding the intervention, experiences of the mindful-
ness sessions, features of the intervention liked and disliked,
and the process of change (or not) as a result of the course. Each
interview was digitally recorded. Interviews were anonymized
and transcribed; any information that may have compromised
confidentiality was omitted before the research team received
the transcripts.
Data Analysis Plan
In order to test the feasibility of this trial, we examined the
number of people expressing interest, screened and enrolled
in the study during the recruitment period. We also looked
at the percentage of people who were eligible of those
screened and percentage of eligible participants who con-
sented to take part in the study. We also looked at the
number of participants who dropped out of the study for
each group and the percentage of participants attending a
different number of sessions. Statistical analysis was carried
out in SPSS v24. All group comparisons were carried out on
an intention-to-treat basis; that is, participants were ana-
lyzed in the group to which they were randomized. Intention
to treat analyses are suggested to help overcome potentially
biasing effects of noncompliance and missing data by
including all participants. In order to include all partici-
pants, those with missing data had their missing values sub-
stituted using the Last Observation Carried Forward method.
We have also conducted a sensitivity analysis, where unim-
puted data was analyzed. For missing items in each
questionnaire, the missing items were replaced with the
average score from the rest of the subscale or scale, as long
as less than 5 scores were missing.
2 (group: Mindfulness, Wait-list) x 4 (time: baseline, mid-
intervention, post-intervention, follow-up) mixed ANOVAs
were conducted to see the effect of group allocation
(between-subjects factor) and time (within-subjects factor) on
both the primary and secondary outcome measures (distress,
depression, anxiety, pain, fatigue, insomnia and impact of Par-
kinson’s on daily activities). Effect sizes (Cohen’s d and partial
eta-squared) were also computed during analysis.
The EQ-5D-3 L questionnaire was collected at baseline, post-
intervention (week 8), and the end of 3-month follow up (week
20). Each EQ-5D-3 L response was linked to a HRQoL weight,
obtained from the UK social tariffs.41 We derived the average
HRQoL reported by the MBI and WLC groups, at every data
collection point. QALYs gained by the mindfulness intervention
were computed as the differences in HRQoL changes between
the MBI and the WLC groups, with respect to the pre-treatment
HRQoL of each group. Our reference-case considered HRQoL
gains during the treatment, and up to 12 weeks after the treat-
ment. The estimate was obtained by adding the QALYs gained
during the treatment (i.e. between-groups differences in the
incremental HRQoL from baseline to week 8, multiplied by
56/365 years) and the QALYs gained from week 8 to week 20
(i.e. between-groups differences in the incremental HRQoL from
week 8 to week 20, multiplied by 84/365 years).
The Incremental Cost-Effectiveness Ratio (ICER) was
derived from data related to the costs of the programme and the
estimates of “QALYs gained” described above. We performed
univariate and probabilistic sensitivity analysis to explore the
uncertainty around the ICER estimate. Detailed results are not
presented here but they are available upon request.
Table 1. Topic Guide for Participants’ Experiences With the Mindfulness Course.
Questions Prompts
1. Can you start by telling me what you were expecting from the
mindfulness sessions?
– What did you think the programme would be like?
– In what ways (if any) did you think it might help you?
2. How did you find the programme overall? – Tell me how you found your first session
– Tell me about the other sessions
– Tell me how you found the homework tasks
3. Can you tell me what you liked about the programme? – What was helpful? Why? How?
– Were there some sessions/ aspects more helpful than others?
4. Can you tell me what you disliked about the programme? – What was unhelpful? Why? How?
– Were there some sessions/ some aspects that were less
helpful than others?
5. Tell me about anything that you feel has changed from having done the
programme?
– Can you tell me what changed? (anything different in your day-
to-day life, the way you are dealing with Parkinson’s?)
– Can you tell me how you came to notice things changing?
– Why/how do you think things changed?
6. Do you have anything else you would like to tell me about your
experiences of this programme that haven’t already covered?
– What would you feed back to the people who put together the
programme?
– What advice would you give to people thinking about taking
part in mindfulness-based programs?
7. What do you think of the questionnaires used and the overall set up of
the study?
– How did you find participating in a course over Skype?
– Any further comments regarding the questionnaires used?
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Qualitative analysis plan. The interviews were analyzed using
inductive thematic analysis. The inductive analysis is a process
of coding the data without trying to fit it into a pre-existing
coding frame, or the researcher’s analytic preconceptions.42
The analysis was conducted following Braun and Clarke’s
guidelines.43 The analysis of the transcripts was conducted in
parallel with ongoing data collection. First, each coding unit in
the first transcript was given a code name, using vocabulary as
close as possible to that used by participants themselves to
avoid prematurely importing preconceptions into the analysis.
This procedure was repeated on the second transcript. When
the same themes recurred, they were provided with the same
label. Initial codes were then applied systematically to the
entire dataset, giving full and equal attention to each data item.
As data analysis proceeded, codes were re-defined as new and
alternative themes arose. Earlier transcripts were re-coded as
codes were developed and refined. During this analysis, the
validity of individual themes about the dataset was considered
and also whether the themes reflected the data set as a whole.
A detailed paper trail recorded the development of the codes
and the relationship between the raw data and the refined
themes and codes. Further, framework analysis techniques
were used, where the final codes were tabulated to inspect the
data for patterns and relationships in the themes between PwP.
Results
Half of the sample were women (n ¼ 30). The majority of the
sample was married or co-habiting (n ¼ 44, 73.3%), had col-
lege or higher education (n ¼ 56, 93.3%) and were White
British (n ¼ 58, 96,7%). As shown in Table 2, the 2 groups
were well matched, regarding gender, age, years since diagno-
sis, disease severity measured by PADLS and anxiety and
depression measured by HADS, with no statistically significant
differences between the groups. The sample size allowed us to
include 6 intervention groups.
Trial Processes (Aim 1)
Recruitment, time and resources. One hundred five potential par-
ticipants expressed interest in taking part in the study within 1
week of advertising. Ninety-one participants were screened for
eligibility between February and August 2016. The interven-
tion was delivered to groups between March and August 2016.
Appropriateness of eligibility criteria and refusal rates. Of the
11 people screened but excluded, 9 (81.81%) had previous
experience in mindfulness training, and 2 (18.18%) had a low
TICS score. Of the 80 eligible participants who received an
invitation and a consent form to the study, 63 (78.75%) con-
sented to take part in the study and 60 were randomized.
Retention rates. Eight participants dropped out of the interven-
tion. Of these, 4 dropped out after attending 2 sessions, 2 par-
ticipants dropped out of the intervention after attending
one session, and 2 participants dropped out before attending
any sessions. Three participants dropped out because they did
not have time, one did not like mindfulness, one did not like
using Skype, one became too ill to participate, one missed too
many sessions due to other commitments, and one had a
bereavement in the family.
All participants were encouraged to complete the follow-up
questionnaires even if they had dropped out of the intervention.
Four participants who dropped out completed the mid-
intervention questionnaires, and one also completed the end
of the intervention and follow-up questionnaires.
Adherence to mindfulness sessions. Twenty-two out of the
30 mindfulness participants (73.3%) attended 4 or more of the
8 sessions, 8 (26.67%) attended all sessions, and 5 (16.67%)
attended 7 sessions, and 6 (20%) attended 6 of the 8 sessions.
The main reasons people cited for not being able to attend were
either problems with their computer or Skype (10 absences) or
being away on holidays (10 absences). Other reasons included
work commitments (6 absences), feeling ill (5 absences) or hav-
ing a doctor’s appointment (5 absences), family commitments (4
absences) and forgetting about the session (2 absences).
The baseline level of disability did not predict the number of
sessions attended (F(1,28) ¼ 2.428, p ¼ 0.13). Similarly, base-
line anxiety (F(1,28) ¼ 1.406, p ¼ 0.246) and depression
(F(1,28) ¼ 0.286, p ¼ 0.597) scores were not associated with
the number of sessions attended.
Potential Efficacy (Aim 2)
Descriptive statistics. As shown in Table 3, there were small
differences in anxiety and depression scores for the mindful-
ness group compared with the control group. Additionally,
there were small differences in pain, fatigue, insomnia and the
impact of Parkinson’s between the 2 groups and corresponding
Table 2. Demographics and Baseline Clinical Characteristics of Participants.
Variable Mindfulness (n ¼ 30) Wait-list (n ¼ 30) Statistical test
Gender, female (n, %) 13 (43.3) 17 (56.7) w2 ¼ 1.067, p ¼ .302
Age, in years (M, SD) 59.50 (11.12) 62.23 (8.96) t(58) ¼ 1.048, p ¼ .299
Years since diagnosis (M, SD) 5.22 (3.55) 6.43 (3.85) t(58) ¼ 1.273, p ¼ .208
Disease severity (PADLS) (M, SD) 2.10 (0.61) 2.13 (0.68) t ¼ .200, p ¼ .0842
Anxiety (HADS) (M, SD) 8.70 (4.23) 7.73 (3.59) t(58) ¼ .960, p ¼ .341
Depression (HADS) (M, SD) 7.23 (3.46) 5.73 (3.00) t(58) ¼ 1.778, p ¼ .08
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small effect sizes (see Table 3). Results of the sensitivity anal-
ysis, where unimputed data was analyzed showed similar effect
sizes and the results are presented in the online supplementary
document.
Primary PROM. Table 4 presents mixed ANOVA results for
depression and anxiety. When performing an intention to treat
analyses, a significant main effect of time for both depression
and anxiety scores was revealed, but no significant main effect
of group and no significant interaction between group and time
was found.
Secondary PROMs. Mixed ANOVA results concerning pain, fati-
gue severity, insomnia and the impact of Parkinson’s on daily
living are also highlighted in Table 4. No main effect for time
was revealed for pain, fatigue, and the impact of Parkinson’s.
However, a significant main effect of time was present for
insomnia scores. Despite this, there was no significant differ-
ence between group scores for any of the secondary measures
and no significant interactions between group and time either.
Potential Effectiveness and Cost-Effectiveness (Aim 3)
HRQoL measures. Both groups (MBI and WLC) experienced an
increase in HRQoL post-intervention (week 8) and a decrease
Table 4. ANOVA Results for Primary and Secondary Outcomes.
df F p Zp2
Anxiety
Time 3, 174 12.61 <.001 .1790
Group 1, 58 .98 .325 .017
Group x Time 3,174 .32 .809 .006
Depression
Time 2.611, 151.431 5.49 .002 .086
Group 1, 58 1.16 .287 .020
Group x Time 2.611, 151.431 2.08 .114 .035
Pain
Time 2.474, 143.493 2.23 .099 .037
Group 1, 58 .00 .996 .000
Group x Time 2.474, 143.493 .69 .533 .012
Fatigue
Time 3, 174 1.78 .154 .030
Group 1, 58 .65 .424 .011
Group x Time 3, 174 1.00 .392 .017
Insomnia
Time 3, 174 66.11 .001 .553
Group 1, 58 .39 .533 .007
Group x Time 3, 174 .89 .446 .015
Impact of Parkinson’s
Time 3, 174 .90 .446 .015
Group 1, 58 .20 .659 .003
Group x Time 3, 174 1.15 .330 .019
Table 3. Estimated Post-Therapy Group Differences (Treatment Effects) for Primary, Secondary Outcomes.
Mindfulness WLC
Mean (SD) CI (LB-UB) Mean (SD) CI (LB-UB) Mean* diff
Effect size*
Cohen’s d
Anxiety baseline 8.70 (4.24) 7.26-10.13 7.73 (3.59) 6.30-9.17 0.97 0.25
mid-intervention 7.27 (4.88) 5.67-8.86 6.40 (3.80) 4.80-8.00 0.87 0.20
post-intervention 7.53 (4.22) 6.07-9.00 6.20 (3.75) 4.74-7.66 1.33 0.33
follow-up 6.97 (4.44) 5.44-8.49 6.17 (3.87) 4.64-7.69 0.80 0.19
Depression baseline 7.23 (3.46) 6.05-8.42 5.73 (3.00) 4.55-6.92 1.50 0.46
mid-intervention 6.27 (3.84) 5.02-7.51 5.13 (2.89) 3.89-6.37 1.14 0.34
post-intervention 5.53 (3.74) 4.26-6.80 5.33 (3.20) 4.06-6.60 0.20 0.06
follow-up 6.03 (4.13) 4.71-7.36 5.33 (3.06) 4.01-6.66 0.70 0.19
Pain Baseline 3.57 (2.01) 2.77-4.37 3.41 (2.38) 2.60-4.21 0.16 0.07
mid-intervention 3.34 (2.10) 2.53-4.16 3.56 (2.35) 2.74-4.37 0.22 0.10
post-intervention 3.21 (2.22) 2.39-4.04 3.32 (2.31) 2.49-4.15 0.11 0.05
follow-up 3.75 (2.17) 2.99-4.60 3.60 (2.47) 2.75-4.45 0.15 0.06
Fatigue Baseline 4.08 (1.30) 3.54-4.62 4.01 (1.62) 3.47-4.54 0.07 0.05
mid-intervention 4.18 (1.30) 3.63-4.73 3.69 (1.69) 3.14-4.24 0.49 0.33
post-intervention 4.20 (1.16) 3.68-4.71 3.96 (1.64) 3.44-4.48 0.24 0.17
follow-up 4.39 (1.30) 3.83-4.94 4.04 (1.72) 3.48-4.60 0.35 0.23
Insomnia Baseline 11.17 (5.38) 9.02-13.31 9.27 (6.31) 7.12-11.41 1.90 0.32
mid-intervention 16.10 (6.68) 13.65-18.55 15.20 (6.72) 12.75-17.65 0.90 0.13
post-intervention 16.00 (6.01) 13.73-18.27 15.40 (6.42) 13.13-17.67 0.60 0.10
follow-up 16.57 (6.01) 14.20-18.93 16.17 (6.89) 13.80-18.53 0.13 0.06
Impact of Parkinson’s Baseline 2.10 (0.61) 1.86-2.34 2.13 (0.68) 1.89-2.37 0.03 0.04
Mid-intervention 2.07 (0.69) 1.82-2.32 2.03 (0.67) 1.79-2.30 0.04 0.06
post-intervention 2.00 (0.74) 1.73-2.27 2.10 (0.71) 1.83-2.37 0.10 0.14
follow-up 2.03 (0.77) 1.73-2,34 2.23 (0.90) 1.93-2.54 0.20 0.24
*Mean difference and effect sizes reflect between groups differences.
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in the next 3 months (week 20). However, the MBI group did
exhibited faster increase rate and slower decrease rate than the
WLC group.
Costs. Since the MBI is complementary, we assumed that all the
patients are following the usual care pathway. We made the
conservative assumption that an MBI did not reduce the health-
care use of those receiving it. Therefore, the cost of receiving
the MBI (a total of £240) was considered to be the only incre-
mental cost between PwP in the WLC group and the
MBI group.
Cost-effectiveness. The intervention provided a QALY gain of
0.0089 QALYs, which resulted from subtracting the
0.0109 QALYs gained by the WLC group from the
0.0197 QALYs gained by the MBI group, see Figure 2, where
QALYs gained by group corresponds to the areas delimited by
the solid lines in orange and blue. The incremental cost-
effectiveness ratio was £27,107. This estimate was based on
rather conservative assumptions: the MBI did not have any
effect on HRQOL after week 20; changes in HRQoL were
gradual (linear); the MBI did not reduce the healthcare use
of those receiving it; and the HRQOL improvement in the
20 week period did not relate to the intervention. The HRQoL
baseline was different for both groups; for this reason, the
simple difference in QALYs between the groups (area
between the blue and orange thick lines, in Figure 2) was not
taken as a valid estimate.
Participants’ Experiences (Aim 3)
All participants who completed the intervention were inter-
viewed at the end of the mindfulness course (n ¼ 25), plus one
participant who dropped out of the study. People were asked
about their experience participating in the online mindfulness
training, what they found helpful and what not so helpful.
Three main themes were identified from the interviews, the
online nature of the intervention, group setting and mindfulness
skills. Pseudonyms are used in the quotes provided to illustrate
each theme.
Online nature of the intervention. Most participants reported some
problems with Skype, with internet connection issues disrupt-
ing their sessions. Despite feeling that face-to-face sessions
potentially could have been better, videoconferences were
identified as convenient, especially for those with mobility
restrictions.
As I say with my Skype connection, a pain in the bum, but certainly
better than having to go backward and forward to a hospital for an
appointment or anything like that (Kathryn, age 50).
The interviews also revealed that participating online helped
form a unique bond since participants were more comfortable
sharing intimate experiences remotely, from their own home.
So that sort of slightest distance with interaction, I found helpful.
Because I think somehow when you are physically in the same
space, you can more easily be intimidated by others; you can be
more prone to groupthink, possibly. I think, as I say, that detach-
ment of the Skype situation I thought worked quite well. (Rebecca,
age 64)
Group setting. The participants enjoyed sharing their experience
with the group and meeting others with Parkinson’s. They
found talking about the exercises helped them express their
feelings verbally and recognize their symptoms.
Yeah we discussed it at length and when we had a bit more of an
explanation and when I heard colleagues in the class using differ-
ent words to explain something it made sense to me. (Adam,
age 52)
The sharing of experiences with others with the same con-
dition led to a reduction of fear for future symptoms and dis-
ease progression, particularly for younger participants with
fewer symptoms.
To get other people’s perspective because quite a few of them were
members of Parkinson’s clubs whereas I’m not and erm I suppose
at this stage I’m not . . . you know I’ve now looked at a group of
people with Parkinson’s and do you know what I thought they’re
not that bad are they. (Adam, age 52)
Mindfulness skills. Following the course, participants reported a
decrease in anxiety and felt more in control of symptoms and
aware of how the condition has made them feel. The mind-
fulness course also helped recently diagnosed people to accept
their diagnosis.
By accepting it and letting it be as it is, you’re not worrying are
you? (Josh, age 53)
I’ve always said, if that’s in describing our condition with other
people who’ve got the same condition, we have to be transparent as
Figure 2. Change in health-related quality of life (HRQoL) in the
mindfulness (MBI) and wait-list control (WLC) group.
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well, and I think the mindfulness has enabled me to be more
transparent with people about how my condition actually makes
me feel a lot of the time. (Kathryn, age 50)
Overall, the experience of the intervention was reported as
positive even by those who felt that they did not directly benefit
from the practice of mindfulness.
we would say how you felt, what they did for you and when they
didn’t do anything much for me, so I was quiet, I was struggling to
say positive things, but I didn’t want to be totally negative, but I
mean I would get something from them, just not as much as I
would have liked. (Eleanor, age 54)
Participants found that the programme helped to develop a
regular practice which led to improvements in their ability to
focus. The mindfulness practice was found to have a positive
effect on other activities such as exercise.
The yoga ones were fine because I do yoga, which helps. I think it
helps me a lot, I do yoga once, maybe twice a week, and I get
meditation at the end. Plus mindfulness comes in quite a lot to yoga
in some of the exercises we do . . . I do benefit from going to yoga,
and the mindfulness has come into it, and I am more aware of it
now. So that is good. (Eleanor, age 54)
The body scan, in particular, was reported as a good tool to
help relaxation, sleep and pain, especially for participants with
less severe symptoms.
I thought that was practical because it’s literally for a few minutes
. . . I mean that’s something I’d certainly take with me because
it’s, it’s like err, like a brainstorm, like a personal brainstorming
reset if you like. (Adam, age 52)
There were some barriers to formal practice relating to
symptoms, but lack of time was the most significant barrier,
especially when meditations were not benefiting the partici-
pant. Most participants had not developed a formal practice
by the end of the programme but used the meditations for
specific causes or symptoms.
It was the time it took to do it. And, and that, that remains, um, the
time it takes to do it (Evelyn, age 68)
I found it difficult putting aside time, but I should have time, step
back and do it . . . I was making myself do it . . . If I had seen it
working I would have probably been more enthusiastic to do it.
(Eleanor, age 54)
Participants approached the programme open-mindedly.
Maybe it’s because I had no expectations because I always try to,
with my condition, I would try to have an open mind, and when-
ever I sort of looked into any sort of clinical trials, or any trials at
all, I try to go in with a completely open mind, so that like I say,
I don’t feel that my expectation gonna end up disappointed.
(Kathryn, age 50)
However, those with anxiety found the programme more
beneficial than those with other symptoms such as concentra-
tion issues.
well I know that my anxiety is Parkinson’s based. Um, so in some
ways, that’s a sort of, um, that’s how I see the benefit of it. I see the
benefit of the techniques. Because, I’ve been diagnosed 4 years,
and my motor aspects are not well advanced. (Jim, age 67)
Some participants found the hour-long sessions and the pro-
gramme overall too short for developing their mindfulness
skills, reporting that it ended abruptly, leaving them without
support.
I wonder actually if it might be useful to do the, like say the
8 weeks, and then, um, sort of wean, wean us off it rather than just
suddenly stop . . . just have a how are you getting on, just a recap,
and maybe just once actually. I don’t know, possibly in a way to
give you something you’ve got to work toward (Elsa, age 61)
Participants suggested follow-up sessions may be benefi-
cial. Alternatively, suggestions of where mindfulness is avail-
able to participants and reminders to keep in touch with other
members of the group could be beneficial. They also reported
that missing sessions, particularly the first session, negatively
affected group bonding and progression within the programme.
it’s just that I thought that at the beginning it, it wasn’t so beneficial
to miss it because, you know, if it had been later on in the course
I would’ve caught up . . . it’s just that I might’ve met more people.
I might’ve bonded better with the people in my group. (Evelyn,
age 68)
Discussion
To date, there is very little research in evaluating the effects of
mindfulness in reducing anxiety and depression in PwP.
The present study assessed the feasibility and potential efficacy
of an online MBI specifically designed for people living with
Parkinson’s. The study met the feasibility aims suggesting that
the adapted online delivered MBI is acceptable to participants
regarding willingness to be screened for and enter a rando-
mized controlled trial, completing the intervention and follow
up measures. Although the intervention did not show any sig-
nificant effect in the selected PROMs, however the overall
effect in HRQOL is shown to be positive. In addition, the
qualitative study showed that mindfulness is a suitable and
acceptable therapy for people living with Parkinson’s.
The current trial shows that the mindfulness courses were of
great interest for people with Parkinson’s, as evidenced by the
large number of potential participants that showed interest in
taking part within a few days of the study being advertised and
the willingness of people to be screened and wait for the mind-
fulness courses. Based on the qualitative findings, the partici-
pants enjoyed sharing their experience with the group and
meeting others living with Parkinson’s. Participants also
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reported and that the intervention led to a reduction in fear of
future symptoms and disease progression. These qualitative
findings support previous research. For instance, several quan-
titative studies have found that MBIs help symptom manage-
ment and control,44 as was identified in the present study’s
interview. The present study thus helps to build on existing
literature suggesting that MBIs are well accepted by PwP and
can have some positive effect. As shown in the qualitative
interviews, the fact that the courses were tailored for PwP made
those courses particularly appealing. The mindfulness course
offered in the current trial was customized to address specific
issues that PwP face.
Further, having group discussions with other PwP appeared
to have the additional advantage of reducing the sense of iso-
lation and reinforcing a sense of camaraderie with people
faced with similar challenges. People felt less alone and were
able to explore further how mindfulness could be used to
address some of their challenges. These group effects may
have enhanced the effectiveness of the MBI. PwP valued the
group dynamic and found it one of the most helpful elements
of the programme. Qualitative research of mindfulness pro-
grams illustrates the benefits of the group environment in
offering a sense of community and support,21,45,46 opportuni-
ties for learning from others,47-49 and motivation to maintain
mindfulness practise.45,48,50 There is less clarity about the
potential benefits and disadvantages of homogeneous
groups.51 Our qualitative findings provide support for the
positive effects of a homogeneous mindfulness group. We did
not assess the group effects quantitatively. To the best of our
knowledge, there is only one large quantitative study (n¼ 606
from 59 groups) that has looked at group processes and found
a significant correlation between group-level variance and
improved outcomes in participants’ levels of psychological
distress.52 Future trials should measure social support as a
direct or indirect effect of mindfulness courses. The role of
group processes should also be explored by introducing a non-
mindfulness-based control group.
This study showed that an online MBI is feasible for PwP.
A significant potential barrier to such intervention within a
population bound by mobility restrictions is the weekly fre-
quency of meetings for 8 weeks. A mindfulness course deliv-
ered via videoconferencing removes logistical barriers that a
face to face intervention can pose and can make it easier for
people to sign up for such interventions and attend sessions.
Further, of the 240 sessions (30 participants x 8 sessions each
participant) only 10 (4%) were missed due to technical diffi-
culties, showing that the technology used was not a major
barrier for people to participate in the MBI. In the qualitative
interviews, people were probed to discuss difficulties with
Skype or the technology used. Even though most participants
mention glitches during the sessions and some confusion over
how to set up Skype and how to join the group, they also talked
about how they would not have the chance to participate in
such a course at all if it was delivered face to face. Videocon-
ference applications are becoming more common, and at the
moment there is a large number of online applications that offer
videoconferencing; Facebook messenger, FaceTime, What-
sApp, Viber, Zoom, Google hangouts to name a few. These
services are becoming easier to use, more sophisticated, with
less technical glitches.
A potent ingredient for any mindfulness course is the daily
meditation practice. A meta-analysis of 43 studies (n ¼ 1427)
of MBIs53 showed that participants’ average mindfulness home
practice time equated to 30 min per day, 6 days per week and
the extend of practice positively correlated with intervention
outcomes. The small body of studies with reduced home prac-
tice identified by the meta-analysis53 showed that participants
in these studies practiced significantly less overall than those
asked to practice for the standard amount of time (i.e., 151 min
vs 174 mins per week). In the current intervention, participants
were asked to complete weekly homework practices, related to
the week’s session, and record them in a diary. However, many
diaries were incomplete, and some entries appeared to have
been created at the last minute. This made it difficult to assess
whether homework had been completed, and it might be an
indication that participants did not engage with the homework
practice. Further, participants reported during the qualitative
interviews that they had difficulties keeping up with the daily
mindfulness practice. Future research studies need to identify
ways to facilitate daily meditation practice and include ele-
ments that can ensure that daily meditation becomes a habit,
an automated response to a predetermined cue.
This efficacy trial also showed issues that need to be
addressed in a future larger trial. Most participants who
dropped out did so after attending 0-2 sessions. A taster day
to show potential participants what an MBI involves could have
increased the attendance rates and reduced the dropout rates.
The taster day could be a short session in a group setting where
the facilitator explains in more detail what mindfulness is and
the type of content and format of each session, followed by a
short mindfulness practice and an inquiry after the practice.
The taster session may end answering questions of the potential
participants and addressing some frequently asked questions
misconceptions, like the origins of mindfulness, whether mind-
fulness is passive resignation, whether mindfulness is a relaxa-
tion technique or whether participants will be able to “control”
their body if they learn to “control” their mind. This taster
session will give participants a better idea of what mindfulness
is and may help them decide whether they would like to com-
mit to the mindfulness course or not.
The present study did not find any significant effects of
mindfulness on depression and anxiety. However, the descrip-
tive statistics showed that both groups had overall low scores of
anxiety and depression, thus leaving little scope for significant
improvement. After consultations with PwP, it was decided not
to have depression and anxiety symptoms as inclusion cri-
teria.18 To retain the inclusivity of these intervention but also
be able to quantify their effectiveness, future studies might
need to consider alternative ways to measure outcomes, for
example a goal oriented outcome measure, where each partici-
pant sets their personal goals at the beginning of the interven-
tion and participants are encouraged to use the mindfulness
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techniques to meet their personal goals. Other widely used
measures of disability and change that can be used as outcome
measures in future psychological interventions in Parkinson’s
may also include the World Health Organization Disability
Assessment Schedule (WHODAS),54 the Patient-specific func-
tional scale,55 the Warwick-Edinburgh Mental Well-Being
Scale56 and the Patient Activation Measure.57 Also, trials could
include explicitly planned moderator analyses, using baseline
anxiety and depression as predictors of differential effects.
The participants found the programme as well as some of the
sessions too short. Modifying the sessions by reducing their
length might not have been appropriate for this population.
The participants may not have had time to explore and process
the concepts introduced in the sessions. It could be argued that
the Parkinson’s population may need as much, if not more, a
mindfulness practice time to learn and practice mindfulness of
that of the general population, to benefit. Therefore, we need to
look at new ways to overcome difficulties the Parkinson’s pop-
ulation may face with practice, such as concentration and fati-
gue, for example, having more extended sessions with more
breaks within them or more frequent but shorter sessions, or
provide other supplemental or optional additional mindfulness
training material that those who want or need it could access,
including pre-recorded audio or video-based exercises. These
changes would allow more considerably more time for sharing
experiences while accommodating the needs of PwP.
Moreover, we have generally observed an increase in
HRQoL for the WLC group from baseline to post-
intervention. Even though we cannot prove the causality, it is
plausible that the HRQoL gain was linked to the intervention.
Although the WLC group did not have the chance to practice
mindfulness systematically, it has been found that participants
in control groups show some improvement in psychological
outcomes and these effects are larger when participants are
allocated in waiting-list groups.58 It seems that the hope of
getting the intervention in the end of the trial can have positive
psychological effect. Thus, being involved in the trial per se is
likely to lead to a positive impact. Further, our reference case
estimated a £27,107 cost-per-QALY of the intervention under
the most conservative assumption (WLC group increasing self-
reported HRQoL for reasons other than the intervention). If we
assumed that at least a 15% of the increase in HRQoL for the
WLC group is linked to the intervention, the cost per additional
QALY gained from the intervention would drop below the
£20,000. Our reference case £27,107 cost-per-QALY is based
on the conservative assumption that there is no effect after
week 20. If we assume that the intervention still has a positive
effect in the HRQoL of participants (in both groups) for
10 additional weeks (in the way described by dashed lines in
Figure 2), then the cost-per-QALY would also drop below
£20,000. Therefore, the reference case estimate could be taken
as an upper boundary, since MBI is likely to be more cost-
effective than the estimates reported here.
Additionally, future research could also attempt to trial the
recommendations to the MBI, revealed in participants’ inter-
views. A follow-up session after the course is completed may
help to encourage the sustained practice of mindfulness, lead-
ing to a more meaningful and longer-lasting change in PwP.
A decrease in HRQoL occurs immediately after the treatment,
and there was no recap session during the 3-month follow up.
Therefore, it is reasonable to assume that having recap sessions
during the 3-month follow up period will slow down the
decrease of HRQoL, or in a stronger assumption, the time-to-
time recap will enable the patients to maintain the highest level
HRQoL. Follow-up sessions could be built into the intervention
by allocating a lead participant in the group and encouraging
the group to continue meeting on a regular basis.
Several additional limitations in this study should be
acknowledged. Due to the nature of recruitment, diagnoses
were self-reported and not verified. The sample was a selective
one, including people interested in mindfulness and with the
devices and skills to use Skype. Naturally, this was a feasibility
study and small in size, so the reliability, particularly for the
treatment effects, will need to be investigated further in future
more extensive studies. This study represents only a limited test
of potential efficacy and generalizability may be limited.
Conclusions
The present study found evidence that an online MBI is feasible
and could work for a larger-scale trial. Preliminary estimations
suggest that the intervention is likely to be cost-effective, com-
pared with a waiting-list group that received only usual care.
Further, including participants with elevated levels of anxiety
and depression might increase the apparent efficacy of the
intervention. Follow-up sessions could have supported future
mindfulness practice. These adaptations may help future MBIs
achieve more significant benefit for PwP.
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